skip to main content

    Updated Visitor Guidelines

 

MENU

 

U-M cancer researcher awarded $6.5M Outstanding Investigator Award to explore precision oncology

University of Michigan Rogel Cancer Center member Arul Chinnaiyan, M.D., Ph.D. has received an Outstanding Investigator Award from the National Cancer Institute, which provides $6.5 million in funding over seven years. The grant will fund research to create new bioinformatics resources and identify new cancer biomarkers to improve diagnosis and ultimately to develop new targeted therapies.

Ovarian Cancer Initiative

The information on this page has moved. Please go to the new ovarian cancer web page.

Ovarian Cancer Research

Discovering New and Better Ovarian Cancer Treatments

The University of Michigan Rogel Cancer Center is dedicated to discovering new and better treatments that advance every aspect of treatment and quality of life for our ovarian cancer patients.

  • Our physicians are at the forefront of ovarian cancer research, including developing new methods to personalize treatment and keep cancer from returning
  • We participate in multiple statewide research-focused organizations, including the Michigan Oncology Quality Consortium (MOQC) and

Quality of Life

Focused on Quality of Life for Ovarian Cancer Patients

Our team at the University of Michigan Rogel Cancer Center provides comprehensive services and resources devoted to optimizing the quality of life of women before, during, and after treatment.

Pages